Literature DB >> 31662150

Therapeutic genome engineering: Implications for South Africa.

J Naidoo1, E Fok, J Scholefield.   

Abstract

South Africa encompasses extraordinary genetic diversity, frequently revealing unique mutations and variations associated with disease. Despite the advances of traditional gene therapy, our understanding of causative mutations in the South African population has, for the most part, contributed to diagnostic rather than therapeutic interventions. Recent developments in genome engineering and its ease of use have released a powerful tool with which to intervene in otherwise untreatable disease. In addition, harnessing this tool for discrete genetic edits provides a mechanism by which screening of new drugs specific to our population's diversity can be accomplished. Here, we use examples of some of the most advanced genome engineering approaches to develop therapeutic strategies that would specifically affect South African individuals.

Mesh:

Year:  2019        PMID: 31662150     DOI: 10.7196/SAMJ.2019.v109i8b.13850

Source DB:  PubMed          Journal:  S Afr Med J


  1 in total

Review 1.  Equitable access to cell and gene therapies in South Africa: opportunities and hurdles.

Authors:  Candice Laverne Hendricks; Marco Alessandrini; Michael Sean Pepper
Journal:  Gene Ther       Date:  2022-01-08       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.